Nuveen’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.8M Buy
128,115
+7,065
+6% +$513K ﹤0.01% 1504
2025
Q4
$9.14M Buy
121,050
+37,759
+45% +$2.38M ﹤0.01% 1605
2025
Q3
$3.31M Hold
83,291
﹤0.01% 2100
2025
Q2
$3.62M Sell
83,291
-27,564
-25% -$1.05M ﹤0.01% 2036
2025
Q1
$4.14M Sell
110,855
-26,971
-20% -$1.04M ﹤0.01% 2018
2024
Q4
$6.24M Buy
137,826
+2,480
+2% +$126K ﹤0.01% 1881
2024
Q3
$7.95M Sell
135,346
-2,552
-2% -$122K ﹤0.01% 1747
2024
Q2
$5.43M Buy
137,898
+6,376
+5% +$309K ﹤0.01% 1906
2024
Q1
$8.74M Buy
131,522
+75,799
+136% +$3.31M ﹤0.01% 1680
2023
Q4
$1.56M Buy
55,723
+38,077
+216% +$763K ﹤0.01% 2524
2023
Q3
$376K Buy
+17,646
New +$389K ﹤0.01% 2923

Other funds holding APGE